U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 21 - 21 of 21 results

FILIPENDULA RUBRA WHOLE

MORE DETAILS

MT26BL24AZ

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2020)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2840f4de-6a61-42ab-85dd-18281b5c795a
First approved in 2020
Source:
21 CFR 333A
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2840f4de-6a61-42ab-85dd-18281b5c795a
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966